Print

Fresenius Kabi USA Launches Treatment for Acetaminophen Overdose  
1/8/2013 9:58:31 AM

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA, LLC today announced the launch of Acetylcysteine Injection. The product is indicated to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen.
//-->